Which has grown faster, VTRS or WST?

Over the past five years, WST grew revenue faster — VTRS at a 3.66% CAGR versus WST at 5.68%.

Does VTRS or WST pay a bigger dividend?

VTRS yields 2.91% and WST yields 0.26% based on trailing dividends and the latest price.

Is VTRS or WST more profitable?

WST runs the higher net margin — VTRS at -2.79% versus WST at 16.98%.

How have VTRS and WST total returns compared?

Over the past 10 years, VTRS delivered -6.37% and WST delivered 15.86% annualized total return. Past performance doesn't predict future results.

Viatris Inc. (VTRS) vs West Pharmaceutical Services, Inc. (WST)

A side-by-side comparison of Viatris Inc. and West Pharmaceutical Services, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of September 10, 2026. Differences are shown without an overall score or investment verdict.

VTRS

Viatris Inc.

$19.91B

$17.10HealthcareDelayed quote: Sep 21, 2026, 4:00 PM EDT

WST

West Pharmaceutical Services, Inc.

$25.46B

$361.73HealthcareDelayed quote: Sep 21, 2026, 3:59 PM EDT

Total return — VTRS vs WST

growth of $100 · dividends reinvested · last 10y

VTRS -48.8% (-6.5%/yr)WST +329.4% (+15.7%/yr)WST compounded faster over this window

Log scale — wide-divergence pair

VTRS WST

VTRS vs WST: by the numbers

•WST is the larger company ($25.46B vs $19.91B market cap).
•WST is profitable (16.98% net margin) while VTRS runs a net loss (-2.79%).
•WST grew revenue faster over the past five years (5.68% vs 3.66% CAGR).
•VTRS pays the higher dividend yield (2.91% vs 0.26%).

Metrics side by side

Valuation

Metric	VTRS	WST
P/E ratio	N/A	46.26
Forward P/E	6.84	40.34
P/S ratio	1.35	7.65
P/B ratio	1.40	8.51
EV / EBITDA	12.37	29.23
FCF yield	9.41%	1.72%

Profitability

Metric	VTRS	WST
Gross margin	34.83%	36.77%
Operating margin	-18.62%	20.64%
Net margin	-2.79%	16.98%
ROE	-2.88%	18.89%
ROIC	-0.29%	15.77%

Dividends

Metric	VTRS	WST
Dividend yield	2.91%	0.26%
Payout ratio	N/A	11.25%

Growth (annualized)

Metric	VTRS	WST
Revenue CAGR (5Y)	3.66%	5.68%
EPS CAGR (5Y)	-41.91%	7.85%
FCF CAGR (5Y)	2.30%	8.74%
Total return CAGR (5Y)	7.33%	-5.84%

Frequently asked

Which has grown faster, VTRS or WST?: Over the past five years, WST grew revenue faster — VTRS at a 3.66% CAGR versus WST at 5.68%.
Does VTRS or WST pay a bigger dividend?: VTRS yields 2.91% and WST yields 0.26% based on trailing dividends and the latest price.
Is VTRS or WST more profitable?: WST runs the higher net margin — VTRS at -2.79% versus WST at 16.98%.
How have VTRS and WST total returns compared?: Over the past 10 years, VTRS delivered -6.37% and WST delivered 15.86% annualized total return. Past performance doesn't predict future results.

Go deeper

Full VTRS analysis Full WST analysis Interactive comparison tool

Dig into the metrics

West Pharmaceutical Services P/E ratio Viatris dividend yield West Pharmaceutical Services dividend yield Viatris ROE West Pharmaceutical Services ROE Viatris operating margin West Pharmaceutical Services operating margin Viatris revenue growth West Pharmaceutical Services revenue growth Viatris free cash flow West Pharmaceutical Services free cash flow

Viatris & West Pharmaceutical Services appear in these rankings

Highest Dividend Yield Stocks 25+ Year Dividend Growers Highest FCF Yield Stocks Highest 10-Year Total Return Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified September 10, 2026.